FDA finds sterile deficiencies at some compounding pharmacies

Numerous safety issues were uncovered during recent inspections of 31 compounding pharmacies in 18 states by the FDA, the agency announced Thursday.Among the safety deficiencies reported were “unidentified black particles floating in vials of supposedly sterile medicine; rust and mold in ‘clean rooms’ … technicians handling supposedly sterile products with bare hands; and employees wearing nonsterile lab coats,” according to a Thursday post on the agency's blog by FDA Commissioner Margaret A. Hamburg, MD.

Full Story →